Diabetes Mellitus as Cancer Risk: A 14-year, Cross-Sectional Analysis

References

• Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. [Internet]. Available from: 10.1016/j.diabres.2019.107843.
   PubMed Web of Science ®Google Scholar
• Xu H-L, Fang H, Xu W-H, Qin G-Y, Yan Y-J, Yao B-D, Zhao N-Q, Liu Y-N, Zhang F, Li W-X, et al. Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai. BMC Cancer. 2015;15:852. 10.1186/s12885-015-1887-4
   PubMed Web of Science ®Google Scholar
• Lin C-C, Chiang J-H, Li C-I, Liu C-S, Lin W-Y, Hsieh T-F, Li T-C. Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer. 2014;14:381. 10.1186/1471-2407-14-381
   PubMed Web of Science ®Google Scholar
• Ballotari P, Vicentini M, Manicardi V, Gallo M, Chiatamone Ranieri S, Greci M, Giorgi Rossi P. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy. BMC Cancer. 2017;17(1):703. 10.1186/s12885-017-3696-4
   PubMed Web of Science ®Google Scholar
• Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166(17):1871–7. 10.1001/archinte.166.17.1871
   PubMedGoogle Scholar
• Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293(2):194–202. 10.1001/jama.293.2.194
   PubMed Web of Science ®Google Scholar
• He X, Shi L, Wu J. Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China. Curr Med Res Opin. 2018;34(6):1089–98. 10.1080/03007995.2017.1421527
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–85. 10.2337/dc10-0666
   PubMed Web of Science ®Google Scholar
• Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract. 2011;17(4):616–28. 10.4158/EP10357.RA
   PubMed Web of Science ®Google Scholar
• Ling S, Brown K, Miksza JK, Howells L, Morrison A, Issa E, Yates T, Khunti K, Davies MJ, Zaccardi F, et al. Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people. Diabetes Care. 2020;43(9):2313–22. 10.2337/dc20-0204
   PubMed Web of Science ®Google Scholar
• Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011;47(13):1928–37. 10.1016/j.ejca.2011.03.003
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2011;26(11):863–76. 10.1007/s10654-011-9617-y
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood. 2012;119(21):4845–50. 10.1182/blood-2011-06-362830
   PubMed Web of Science ®Google Scholar
• Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2012;28(2):109–22. 10.1002/dmrr.1291
   PubMed Web of Science ®Google Scholar
• Zhu Z, Wang X, Shen Z, Lu Y, Zhong S, Xu C. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer. 2013;13:310. 10.1186/1471-2407-13-310
   PubMed Web of Science ®Google Scholar
• Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365–74. 10.1007/s00125-007-0681-5
   PubMed Web of Science ®Google Scholar
• Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856–62. 10.1002/ijc.22717
   PubMed Web of Science ®Google Scholar
• Lee JY, Jeon I, Lee JM, Yoon JM, Park SM. Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies. Eur J Cancer. 2013;49(10):2411–23. 10.1016/j.ejca.2013.02.025
   PubMed Web of Science ®Google Scholar
• Ge Z, Ben Q, Qian J, Wang Y, Li Y. Diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies. Eur J Gastroenterol Hepatol. 2011;23(12):1127–35. 10.1097/MEG.0b013e32834b8d73
   PubMed Web of Science ®Google Scholar
• Lee JY, Jeon I, Kim JW, Song YS, Yoon JM, Park SM. Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer. 2013;23(3):402–12. 10.1097/IGC.0b013e31828189b2
   PubMed Web of Science ®Google Scholar
• Stattin P, Björ O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30(3):561–7. 10.2337/dc06-0922
   PubMed Web of Science ®Google Scholar
• Ragozzino M, Melton LJ, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982;35(1):13–9. 10.1016/0021-9681(82)90025-x
   PubMedGoogle Scholar
• Khokhar B, Jette N, Metcalfe A, Cunningham CT, Quan H, Kaplan GG, Butalia S, Rabi D. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016;6(8):e009952. 10.1136/bmjopen-2015-009952
   PubMed Web of Science ®Google Scholar
• Lash TL, Cole SR. Immortal Person-time in studies of cancer outcomes. J Clin Oncol. 2009;27(23):e55–e56. 10.1200/JCO.2009.24.1877
   PubMed Web of Science ®Google Scholar
• RStudio Team. RStudio: Integrated development for R. Boston (MA): RStudio, PBC; 2020. http://www.rstudio.com/.
   Google Scholar
• Naing NN. Easy way to learn standardization: Direct and indirect methods. Malays J Med Sci. 2000;7(1):10–5.
   PubMedGoogle Scholar
• Ahmad OB, Boschi Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of rates: A new WHO Standard. GPE Discussion Paper Series, EIP/GPE/EBD, World Health Organization; 2001. No.31.
   Google Scholar
• Curtin LR, Klein RJ. Direct standardization (age-adjusted death rates). Healthy People 2000 Stat Notes. 1995;(6):1–10.
   PubMedGoogle Scholar
• Chompootweep S, Tankeyoon M, Yamarat K, Poomsuwan P, Dusitsin N. The menopausal age and climacteric complaints in Thai women in Bangkok. Maturitas. 1993;17(1):63–71. 10.1016/0378-5122(93)90124-z
   PubMed Web of Science ®Google Scholar
• Yamagiwa K, Ichikawa K. Experimental study of the pathogenesis of carcinoma. CA Cancer J Clin. 1977;27(3):174–81. 10.3322/canjclin.27.3.174
   PubMed Web of Science ®Google Scholar
• Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol. 2007;27(10):3569–77. 10.1128/MCB.01447-06
   PubMed Web of Science ®Google Scholar
• Zhang H, Pelzer AM, Kiang DT, Yee D. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Cancer Res. 2007;167(1):391–7. 10.1158/0008-5472.CAN-06-1712
   PubMed Web of Science ®Google Scholar
• Tseng HW, Shiue YL, Tsai KW, Huang WC, Tang PL, Lam HC. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan. Med (Baltimore). 2016;95(26):e4070. 10.1097/MD.0000000000004070
   PubMed Web of Science ®Google Scholar
• Szablewski L. Diabetes mellitus: influences on cancer risk. Diabetes Metab Res Rev. 2014;30(7):543–53. 10.1002/dmrr.2573
   PubMed Web of Science ®Google Scholar
• Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond). 2009;116(7):539–64. 10.1042/CS20080253
   PubMed Web of Science ®Google Scholar
• Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32. 10.1002/hep.23594
   PubMed Web of Science ®Google Scholar
• Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology. 2010;52(1):155–63. 10.1002/hep.23641
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhang X, Xu H, Smith-Warner SA, Xu D, Fang H, Xu WH. Cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data. Endocr Connect. 2018;7(12):1415–23. 10.1530/EC-18-0381
   PubMed Web of Science ®Google Scholar
• Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72(1):83–9. 10.1210/jcem-72-1-83
   PubMed Web of Science ®Google Scholar
• Kazer RR. Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer. 1995;62(4):403–6. 10.1002/ijc.2910620408
   PubMed Web of Science ®Google Scholar
• Key TJ, Pike MC. The dose-effect relationship between “unopposed” oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer. 1988;57(2):205–12. 10.1038/bjc.1988.44
   PubMed Web of Science ®Google Scholar
• Berrington de González A, Green J, International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007;120(4):885–91.
   PubMed Web of Science ®Google Scholar
• Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687–91. 10.1002/ijc.11141
   PubMed Web of Science ®Google Scholar
• Ekachampaka P, Wattanamano N. Thailand Health Profile 2005-2007. In: Wibulpolprasert S, editor. Health status and health problems of Thai people. Bangkok (Thailand): Bureau of Policy and Strategy, Ministry of Public Health; 2011. p. 161–256.
   Google Scholar